Application Nr Approved Date Route Status External Links
ANDA209613 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Teriflunomide Tablets Are Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease And Active Secondary Progressive Disease In Adults. Teriflunomide Is A Pyrimidine Synthesis Inhibitor Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease And Active Secondary Progressive Disease, In Adults. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Teriflunomide TERIFLUNOMIDE ZINC13512456

Comments